Skip to Main Content
Project on Government Oversight
FacebookTwitter
Share on Facebook
CURRENT_PAGE_TITLE
Cancel
Share on Yahoo!
CURRENT_PAGE_TITLE
Cancel
Share on MySpace
CURRENT_PAGE_TITLE
Cancel
Share on Twitter
A short url will be added to the end of your Tweet.

Cancel
Share on LinkedIn
CURRENT_PAGE_TITLE
Cancel


Public Health Letters


POGO Letter: FDA Advisors on Yaz and Yasmin Have Industry Ties
January 11, 2012


POGO Letter Urges FDA Not to Weaken Conflict of Interest Standards at Center for Drug Evaluation and Research
August 3, 2011


POGO Letter to FDA Commissioner Hamburg Concerning the Potentially Dangerous Interaction of the Drugs Seroquel and Methodone
July 19, 2011


POGO Letter to OMB Director Jacob Lew Regarding Proposed NIH Rule on Financial Arrangements between Researchers and Industry
July 11, 2011


POGO's Letter to President Obama on Bioethics Commission Chair's Ghostwriting Practices
July 11, 2011


POGO asks DHHS Secretary Sebelius to reinvestigate FDA's negligent oversight of unsafe medical devices
January 13, 2011


POGO's fourth reply to letters from Dr. Schatzberg and Dr. Nemeroff
December 23, 2010


POGO's third reply to letters from Dr. Schatzberg and Dr. Nemeroff
December 16, 2010


POGO's second reply to letter from Dr. Schatzberg and Dr. Nemeroff
December 9, 2010


POGO's first reply to letters from Dr. Schatzberg and Dr. Nemeroff
December 8, 2010


POGO Letter to NIH on Ghostwriting Academics
November 29, 2010


POGO Letter to NIH Director Francis Collins Again Urges Public Disclosure of Medical Researchers' Financial Ties to Industry
November 19, 2010


POGO Letter to NIH Official on Possible Value of Testing Statins for Pandemic Flu
October 28, 2010


POGO Letter to FDA Commissioner Margaret Hamburg Regarding Potentially Dangerous Drug Interaction Invovling Seroquel and Methadone
October 25, 2010


POGO's letter to Deputy HHS IG on FDA's CDRH's low standard of medical devices approval
September 28, 2010


The Finances Of FDA Advisory Committee Members: If Information Must Be Withheld, Let It Be Done Openly
August 16, 2010


POGO letter to NIH Director Collins: Ethics reform at NIH needs a more ethical leader
June 12, 2010


POGO Letter to DHHS on Pandemic Flu Vaccine: Answer Questions Instead of Dodging Them
April 2, 2010


POGO Letter To NIH Director: Medical Researchers Should Be Made To Publicly Disclose Possible Conflicts Of Interest
March 15, 2010


POGO Letter To NIH Director Francis Collins Urges Public Disclosure of Medical Researchers' Financial Ties To Industry
March 11, 2010


POGO letter to Secretary Sebelius: Use emergency powers to support study on prevention of deaths from H1N1 flu
November 13, 2009


POGO asks Secretary Sebelius to disclose mistakes that led to vaccine shortage
October 30, 2009


POGO's letter to Commissioner Hamburg regarding medical devices
October 14, 2009


POGO Letter to Secretary Sebelius regarding H1N1 Vaccine Shortage
September 30, 2009


POGO letter to DHHS Secretary Sebelius: Greater transparency in the flu vaccine program is urgently needed
August 26, 2009


POGO Letter to Secretary Sebelius Regarding Production of Vaccine for H1N1 Swine Flu
July 20, 2009


POGO adds Public Comment regarding conflicts of interest among NIH grantees
July 9, 2009


POGO Letter to FDA's Daniel Schultz MD regarding a policy decision by CDRH to discontinue inspections of nonclinical laboratories
June 10, 2009


POGO Asks FDA Head to Have Deadly Syringe Incident Investigated
June 6, 2009


POGO letter to FDA's Daniel Schultz MD regarding the lack of GLP inspections
March 17, 2009


POGO Follow-up letter to CDRH Director Daniel Schultz
May 13, 2008


POGO Letter to CDRH Director Daniel Schultz regarding a series of questions about the apparent decision not to enforce the GLP regulation
April 30, 2008


POGO Letter to Senator Kennedy Regarding the Production of the Pandemic Flu Vaccine
March 6, 2008


Scientists Who Serve
November 15, 2006


Paid Consulting and Conflicts of Interest at NIH
July 26, 2005